BACKGROUND: The inherited deficiency of C1-inhibitor (C1-INH), which can be quantitative (type I) or qualitative (type II), is characterised by recurrent attacks of edema and it is known as hereditary angioedema due to C1-INH deficincy (HAE-C1-INH). The frequency of symptoms varies widely among patients and in the same patient during life. OBJECTIVE: To identify laboratory markers of disease severity in HAE-C1-INH patients. METHODS: We studied 162 patients with differently severe HAE-C1-INH during remission, 31 HAE-C1-INH patients during attacks and 81 normal controls, evaluating complement parameters, spontaneous plasma kallikrein activity, the capacity of plasma to inhibit exogenous kallikrein activity and cleavage of high-molecular-weight kininogen (HK). Sixty-five HAE-C1-INH patients were screened for mutations in the C1-INH gene. RESULTS: As expected, plasma C1-INH levels and activity and C4 levels were low in the HAE-C1-INH patients. Spontaneous plasma kallikrein activity in patients in remission was higher than in controls (P=0.001), and increased during acute attacks (P=0.01), whereas the capacity of inhibiting kallikrein activity was lower in patients in remission than in controls (P=0.001) and further reduced during attacks (P=0.001). HAE-C1-INH patients in remission had higher levels of cleaved HK than controls (P=0.001), and these further increased during acute attacks (P=0.001). Cleaved HK levels were higher in highly symptomatic HAE-C1-INH patients than in those with less frequent attacks (P=0.001). Thirty-five different mutations in the C1-INH gene were equally distributed in patients with different attack frequencies. CONCLUSIONS: Measuring plasma levels of cleaved HK may be a sensitive mean of assessing disease severity in HAE-C1-INH patients.

High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin mediated angioedema due to hereditary c1-inhibitor deficiency / C. Suffritti , A. Zanichelli, L. Maggioni, B. Bonanni, M. Cugno, M. Cicardi. - In: CLINICAL AND EXPERIMENTAL ALLERGY. - ISSN 0954-7894. - 44:12(2014), pp. 1503-1514.

High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin mediated angioedema due to hereditary c1-inhibitor deficiency

C. Suffritti;M. Cugno;M. Cicardi
2014

Abstract

BACKGROUND: The inherited deficiency of C1-inhibitor (C1-INH), which can be quantitative (type I) or qualitative (type II), is characterised by recurrent attacks of edema and it is known as hereditary angioedema due to C1-INH deficincy (HAE-C1-INH). The frequency of symptoms varies widely among patients and in the same patient during life. OBJECTIVE: To identify laboratory markers of disease severity in HAE-C1-INH patients. METHODS: We studied 162 patients with differently severe HAE-C1-INH during remission, 31 HAE-C1-INH patients during attacks and 81 normal controls, evaluating complement parameters, spontaneous plasma kallikrein activity, the capacity of plasma to inhibit exogenous kallikrein activity and cleavage of high-molecular-weight kininogen (HK). Sixty-five HAE-C1-INH patients were screened for mutations in the C1-INH gene. RESULTS: As expected, plasma C1-INH levels and activity and C4 levels were low in the HAE-C1-INH patients. Spontaneous plasma kallikrein activity in patients in remission was higher than in controls (P=0.001), and increased during acute attacks (P=0.01), whereas the capacity of inhibiting kallikrein activity was lower in patients in remission than in controls (P=0.001) and further reduced during attacks (P=0.001). HAE-C1-INH patients in remission had higher levels of cleaved HK than controls (P=0.001), and these further increased during acute attacks (P=0.001). Cleaved HK levels were higher in highly symptomatic HAE-C1-INH patients than in those with less frequent attacks (P=0.001). Thirty-five different mutations in the C1-INH gene were equally distributed in patients with different attack frequencies. CONCLUSIONS: Measuring plasma levels of cleaved HK may be a sensitive mean of assessing disease severity in HAE-C1-INH patients.
angioedema; biomarkers; C1-inhibitor deficiency; disease severity; high-molecular-weight kininogen; kallikrein
Settore MED/09 - Medicina Interna
Article (author)
File in questo prodotto:
File Dimensione Formato  
Suffritti_et_al-2014-Clinical_&_Experimental_Allergy.pdf

non disponibili

Tipologia: Publisher's version/PDF
Dimensione 357.06 kB
Formato Adobe PDF
357.06 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/234951
Citazioni
  • ???jsp.display-item.citation.pmc??? 23
  • Scopus 63
  • ???jsp.display-item.citation.isi??? 0
social impact